CareDx (CDNA) Misses Q2 EPS by 9c, Maintains FY Rev. Guidance
CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.27), $0.09 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $7.13 million versus the consensus estimate of $7.28 million.
CareDx sees FY2015 revenue of $28-30 million, versus the consensus of $29.60 million.
For earnings history and earnings-related data on CareDx (CDNA) click here.